Azacytin 300 mg Tablet

Brand Name: Azacytin

Molecule: Azacitidine

Strength: 300 mg

Quantity: 14 Tablets

Form: Tablet

Packaging Type: Bottle

Country of Origin: India

Description

Azacytin 300 mg Tablet contains Azacitidine, an antineoplastic medicine used in the treatment of myelodysplastic syndromes (MDS) and certain types of blood cancers. It helps improve bone marrow function and slows abnormal cell growth under specialist supervision.

Benefits

Helps improve red, white, and platelet blood cell counts
Reduces need for blood transfusions
Slows abnormal cell growth in bone marrow
Improves quality of life in MDS patients
Oral form offers convenience for long-term therapy

Indications and Usage

Azacytin 300 mg Tablet is indicated for:

Myelodysplastic Syndromes (MDS)
Chronic Myelomonocytic Leukemia (CMML)
Acute Myeloid Leukemia (AML) (certain cases)
Patients with abnormal or immature blood cell production
Reducing transfusion dependency

How it Works

Azacitidine works by inhibiting abnormal DNA methylation in bone marrow cells. This helps restore normal cell growth and function, reducing the proliferation of cancerous or immature blood cells.

Dosage & Administration

Dose is determined individually by the oncologist
Taken orally with water; follow exact schedule provided
Do not crush or chew tablets
Avoid missed doses—consistency is important
Regular monitoring of blood counts and organ function required

Use only under specialist supervision.

Side Effects

Common side effects:

Nausea, vomiting
Fatigue or weakness
Diarrhea or constipation
Injection-site irritation (if injectable form is used)
Low blood counts (anemia, neutropenia, thrombocytopenia)

Serious side effects (seek urgent care):

Severe infection or fever
Unusual bleeding or bruising
Breathing difficulty
Kidney or liver dysfunction
Severe allergic reactions

Warning and Precaution

Not recommended during pregnancy or breastfeeding
Increased risk of infections due to low immunity
Monitor kidney, liver, and blood counts frequently
Avoid contact with sick individuals
Report fever, bleeding, or severe fatigue immediately
Inform doctor if taking other chemotherapy or immunosuppressive drugs

Osimertinib (Tagrisso) for Lung Cancer: What You Need to Know

Introduction Lung cancer is one of the most common and deadly cancers globally. The most common type of lung cancer is non-small

January 30, 2025

Rated 0 out of 5

0 reviews

Rated 5 out of 5

Rated 4 out of 5

Rated 3 out of 5

Rated 2 out of 5

Rated 1 out of 5

Reviews

Clear filters

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Product	Manufacturer / Marketed By	Price
Hemazide O 300 mg Tablet	Cadila Pharmaceuticals Ltd	Ask for Price
MDS-O 300 mg Tablet	Adley	Ask for Price
BD Zadine 300 mg Tablet	N/A	Ask for Price
Azarest 300 mg Tablet	Everest Pharma	Ask for Price

Call : +63 952 488 3302